Growth Metrics

Exagen (XGN) Total Non-Current Liabilities (2018 - 2025)

Exagen (XGN) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $38.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities rose 10.45% year-over-year to $38.8 million, compared with a TTM value of $38.8 million through Dec 2025, up 10.45%, and an annual FY2025 reading of $38.8 million, up 10.45% over the prior year.
  • Total Non-Current Liabilities was $38.8 million for Q4 2025 at Exagen, up from $38.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $45.1 million in Q1 2022 and bottomed at $30.5 million in Q1 2024.
  • Average Total Non-Current Liabilities over 5 years is $36.8 million, with a median of $35.5 million recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities grew 29.28% in 2022, then decreased 28.24% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $37.1 million in 2021, then grew by 15.61% to $42.9 million in 2022, then decreased by 20.98% to $33.9 million in 2023, then rose by 3.71% to $35.1 million in 2024, then increased by 10.45% to $38.8 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for XGN at $38.8 million in Q4 2025, $38.1 million in Q3 2025, and $37.6 million in Q2 2025.